health π Canada greenlights Moderna's Ebola vaccine trials
Canada has authorized Moderna to start clinical trials for an Ebola vaccine targeting the Bundibugyo strain. This Phase 1 trial will take place in Canada, assessing safety, dosage, and side effects in healthy participants. The vaccine uses the same mRNA tech as Moderna's Covid-19 shot, and Canada plans to manufacture it domestically. Currently, there is no approved treatment for the Bundibugyo variant of Ebola. Positive results could lead to larger trials, given over 1,700 deaths in the DRC since May.